Details
Stereochemistry | RACEMIC |
Molecular Formula | C24H27N |
Molecular Weight | 329.4779 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(CC1=CC=CC=C1)NCCC(C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=IFFPICMESYHZPQ-UHFFFAOYSA-N
InChI=1S/C24H27N/c1-20(19-21-11-5-2-6-12-21)25-18-17-24(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,20,24-25H,17-19H2,1H3
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2095229 |
|||
Target ID: CHEMBL1980 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12130695 |
0.72 µM [IC50] | ||
Target ID: CHEMBL6093 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2933041 |
|||
Target ID: Q9H1R3 Gene ID: 85366.0 Gene Symbol: MYLK2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/2933041 |
PubMed
Title | Date | PubMed |
---|---|---|
[Prevention of isoproterenol-induced lesions in the rat myocardium by prenylamine]. | 1975 Sep-Oct |
|
An overall review on prenylamine mechanisms of action in experimental models of myocardial damage. | 1982 |
|
Atrio-ventricular block after administration of lignocaine in patients treated with prenylamine. | 1982 Mar |
|
Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. | 1993 Dec 1 |
|
[Modulation of serine/threonine protein kinase activity in chloramphenicol-resistant mutants of Streptomyces avermitilis]. | 2004 May-Jun |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13978340
270 mg of prenylamine per day for one month
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
C01DX02
Created by
admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
|
||
|
WHO-VATC |
QC01DX02
Created by
admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
|
||
|
WHO-ATC |
C01DX52
Created by
admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
|
||
|
WHO-VATC |
QC01DX52
Created by
admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C170345
Created by
admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
|
PRIMARY | |||
|
K2OH82Z000
Created by
admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
|
PRIMARY | |||
|
SUB10030MIG
Created by
admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
|
PRIMARY | |||
|
100000081629
Created by
admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
|
PRIMARY | |||
|
DB04825
Created by
admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
|
PRIMARY | |||
|
9801
Created by
admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
|
PRIMARY | |||
|
390-64-7
Created by
admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
|
PRIMARY | |||
|
D011299
Created by
admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
|
PRIMARY | |||
|
PRENYLAMINE
Created by
admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
|
PRIMARY | |||
|
CHEMBL24072
Created by
admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
|
PRIMARY | |||
|
DTXSID0048555
Created by
admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
|
PRIMARY | |||
|
m9125
Created by
admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
|
PRIMARY | Merck Index | ||
|
1196
Created by
admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
|
PRIMARY | |||
|
2261
Created by
admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
|
PRIMARY | |||
|
206-869-4
Created by
admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
|
PRIMARY | |||
|
8674
Created by
admin on Fri Dec 15 17:00:55 GMT 2023 , Edited by admin on Fri Dec 15 17:00:55 GMT 2023
|
PRIMARY | RxNorm |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)